首页> 外国专利> Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells

Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells

机译:源自产后哺乳动物胎盘的类胚胎干细胞及其用途和治疗方法

摘要

The present invention provides compositions and methods of using embryonic like stem cells that originate from a post-partum placenta with conventional cord blood 5 compositions or other stem or progenitor cells. The embryonic-like stem cells can be used alone or in a mixture with other stem cell populations. In accordance with the present invention, the embryonic-like stem cells may be mixed with other stem cell populations, including but not limited to, umbilical cord blood, fetal and neonatal hematopoietic stem cells and progenitor cells, human stem cells and progenitor cells derived from bone marrow. The 10 embryonic-like stem cells and the mixed population of embryonic-like stem cells and stem cells have a multitude of uses and applications, including but not limited to, therapeutic uses for transplantation and treatment and prevention of disease, and diagnostic and research uses.
机译:本发明提供了组合物和方法,该组合物和方法使用来源于产后胎盘的胚胎样干细胞与常规脐带血5组合物或其他干细胞或祖细胞。胚胎样干细胞可单独使用或与其他干细胞群混合使用。根据本发明,可以将胚胎样干细胞与其他干细胞群体混合,包括但不限于脐带血,胎儿和新生儿造血干细胞和祖细胞,人干细胞和源自祖细胞的祖细胞。骨髓。十种类胚胎干细胞以及类胚胎干细胞和干细胞的混合种群具有多种用途和应用,包括但不限于用于移植,治疗和预防疾病的治疗用途以及诊断和研究用途。

著录项

  • 公开/公告号AU2011202711B2

    专利类型

  • 公开/公告日2012-02-02

    原文格式PDF

  • 申请/专利权人 ANTHROGENESIS CORPORATION;

    申请/专利号AU20110202711

  • 发明设计人 HARIRI ROBERT J.;

    申请日2011-06-07

  • 分类号A61K35/12;A61K35/28;A61K35/48;A61P3/10;A61P9;A61P9/10;A61P17/02;A61P19;A61P21;A61P25;A61P25/02;A61P25/28;A61P29;A61P37/06;C12N5/02;C12N5/073;C12N5/074;

  • 国家 AU

  • 入库时间 2022-08-21 17:19:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号